研究業績

2021

• 21.

  2021

  Nakamura, Y. Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study).ESMO Open. 2021 Dec;6(6):100325. doi: 10.1016/j.esmoop.2021.100325. Epub 2021 Nov 25.PMID: 34839104

• 20.

  2021

  Saiki, H. A Microbiome-Derived Peptide Induces Apoptosis of Cells from Different Tissues.Cells.2021 Oct 26;10(11):2885.doi: 10.3390/cells10112885.

• 19.

  2021

  Nakai, Y. Progressive vitiligo induced by recurrent melanoma. Clinical Case Reports, accepted.

• 18.

  2021

  Nakanishi, T. Janus kinase inhibitors ameliorated gastrointestinal amyloidosis and hypoalbuminemia in persistent dermatitis mouse model. International Journal of Molecular Sciences, accepted.

• 17.

  2021

  Yamanaka, K. Special Issue: “Skin Disease and Comorbidities”. Journal of Clinical Medicine, 2021, 10, 5754.

• 16.

  2021

  Kondo, M. Possible HSP reactivation post COVID-19 vaccination and booster. Clinical Case Reports, accepted.

• 15.

  2021

  Kondo, M. Alternation of the cutaneous microbiome of herpes zoster lesion in a patient with severe coronavirus disease 2019. International Journal of Dermatology, accepted.

• 14.

  2021

  Kondo, M. The presence of Tularemia infection in patients with Japanese spotted fever. J Dermatol. 2021 Aug;48(8):1277-1280. doi: 10.1111/1346-8138.15934. Epub 2021 May 5.

• 13.

  2021

  Goto, H. Successful treatment of ulcerative-type pyoderma gangrenosum with a combination therapy of oral prednisolone, vacuum-assisted closure, and skin grafting. Case Reports in Dermatology, accepted.

• 12.

  2021

  Nakanishi, T. Reduction in Tumor Lesions and Exacerbation of Psoriatic Rash after Septic Shock in a Patient with Extramammary Paget’s Disease. Case Reports in Oncology, accepted.

• 11.

  2021

  Kondo, M. Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID-19 infection: a case report with detailed laboratory data. Clinical Case Reports, accepted.

• 10.

  2021

  Nakayama, Y. Whether to maintain or strengthen the treatment for pyoderma gangrenosum ulcerative type may depend on the response after two to four-week treatment intervention: the outcome of three cases with details clinical course. Clinical Case Reports, accepted.

• 9.

  2021

  Kondo, M. Subcutaneous Aspergillus nodule with cutaneous Enterococcus infection.Oxford Medical Case Reports, accepted.

• 8.

  2021

  Habe, K. The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease. Clin Rheumatol. 2021 Jun 16. doi: 10.1007/s10067-021-05781-w. Online ahead of print.

• 7.

  2021

  Kondo, M. A case of α-gal unrelated red meat induced urticaria treated by omalizumab. Case Reports in Dermatology, accepted.

• 6.

  2021

  Yamanaka, K. Psoriatic Transversal Nail grooves on Biologics. Clinical Case Reports, accepted.

• 5.

  2021

  Kondo, M. Lymphocyte transformation test: the multiple positive results turned to all negative after influenza infection. Clinical Case Reports, accepted.

• 4.

  2021

  Sugioka, K. Three cases of lymphocytic infiltration of the eyelid. Dermatopathology (Basel). 2021 May 8;8(2):124-129. doi: 10.3390/dermatopathology8020018.

• 3.

  2021

  Kondo, M. Dominance of methicillin resistant Staphylococcus aureus in a Japanese infant with recessive dystrophic epidermolysis bullosa. Case Reports in Dermatology, 2021 Jun 8;13(2):278-281. doi: 10.1159/000516354.

• 2.

  2021

  Yamanaka, K. Pathophysiology of psoriasis: A review. J Dermatol, 2021 May 21. doi: 10.1111/1346-8138.15963.

• 1.

  2021

  Kondo, M. Immunoglobulin G levels against Staphylococcus aureus maintained before and after treatment of severe atopic dermatitis. J Dermatol. 2021 Jun;48(6):e277-e278. doi: 10.1111/1346-8138.15871.